[1]刘江涛 综述 陈谦学 审校.磁共振灌注成像技术在脑胶质瘤诊疗中的应用进展[J].中国临床神经外科杂志,2020,(04):248-250.[doi:10.13798/j.issn.1009-153X.2020.04.020]
点击复制

磁共振灌注成像技术在脑胶质瘤诊疗中的应用进展()
分享到:

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
期数:
2020年04期
页码:
248-250
栏目:
综述
出版日期:
2020-04-30

文章信息/Info

文章编号:
1009-153X(2020)04-0243-03
作者:
刘江涛 综述 陈谦学 审校
430060 武汉,武汉大学人民医院神经外科(刘江涛、陈谦学)
关键词:
脑胶质瘤磁共振灌注成像诊断治疗
分类号:
R 739.41; R 445.2
DOI:
10.13798/j.issn.1009-153X.2020.04.020
文献标志码:
A

参考文献/References:

[1] 柯居中,郑 莹,卢 伟. 中国2008年脑和神经系统肿瘤 发病、死亡和患病情况的估计及预测[J]. 中华流行病学 杂志,2012,33(10):1060-1063.
[2] Hirai T, Murakami R, Nakamura H, et al. Prognostic value of perfusion MR imaging of high-grade astrocytomas: long- term follow up study [J]. AJNR Am J Neuroradiol, 2008, 29: 1505-1510.
[3] 丁芳芳,袁 涛,全冠民,等. 脑高级别胶质瘤ASL灌注成 像研究进展[J]. 国际医学放射学杂志,2014,37:328-331.
[4] Direksunthorn T, Chawalparit O, Sangruch T, et al. Diagnos- tic performance of perfusion MRI in differentiating low- grade and high-grade gliomas: advanced MRI in glioma: a Siriraj project [J]. J Med Assoc Thai, 2013, 96: 1183-1190.
[5] 方靖琴,王舒楠,陈金华,等. 磁共振灌注加权成像评价脑 胶质瘤微血管的实验研究[J]. 临床放射学杂志,2012, 31:1487-1491.
[6] Falk A, Fahlstrom M, Rostrup E, et al. Discrimination between glioma grades II and III in suspected low-grade gliomas using dynamic contrast-enhancedand dynamic susceptibility contrast perfusion MR imaging: a histogram analysis approach [J]. Neuroradiology, 2014, 56: 1031- 1038.
[7] 黄 杰,李晓光,康厚艺,等. DSC-MRI和DCE-MRI定量 分析在脑胶质瘤分级诊断中的应用[J]. 第三军医大学学 报,2015,37:672-677.
[9] 朱记超,娄明武,张方璟,等. 动脉自旋标记技术在脑肿瘤 术前评估中的应用研究[J]. 临床放射学杂志,2012,31 (12):1688-1693.
[10] Shiroishi MS, Castellazzi G, Boxerman JL, et al. Principles of T2*-weighted dynamic susceptibility contrast MRI technique in brain tumor imaging [J]. J Magn Reson Imaging, 2015, 41: 296-313.
[11] Xing Z, You RX, Li J, et al. Differentiation of primary cen- tral nervous system lymphomas from high-grade gliomas by rCBV and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging [J]. Clin Neuroradiol, 2014, 24: 329- 336.
[12] Xiao HF, Chen ZY, Lou X, et al. Astrocytic tumour grading: a comparative study of three-dimensional pseudocontinuous arterial spin labelling, dynamic susceptibility contrast- enhanced perfusion-weighted imaging, and diffusion- weighted imaging [J]. Eur Radiol, 2015, 25(12): 3423-3430.
[13] Neskamatuszewska M, Bladowska J, Sasiadek M, et al. Dif- ferentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multipa- rametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-searching for a practical approach [J]. PLoS One, 2018, 13(1): 1-10.
[14] Toh CH, Wei K, Chang C, et al. Differentiation of brain abscesses from glioblastomas and metastatic brain tumors: comparisons of diagnostic performance of dynamic suscep- tibility contrast-enhanced perfusion MR imaging before and after mathematic contrast leakage correction [J]. PLoS One, 2014, 9(10): 1-7.
[15] Ulmer S, Helle M, Jansen O, et al. Intraoperative dynamic susceptibility contrast weighted magnetic resonance imaging (iDSC-MRI)--technical considerations and feasibility [J]. Neuroimage, 2009, 45(1): 38-43.
[16] Cebeci H, Aydin O, Ozturk-Isik E, et al. Assesment of perfusion in glial tumors with arterial spin labeling: compa- rison with dynamic susceptibility contrast method [J]. J Eur Radiol, 2014, 83: 1914-1919.
[17] Hirai T, Kitajima M, Nakamura H, et al. Quantitative blood flow measurements in gliomas using arterial spin -labeling at 3 T: intermodality agreement and inter- and intra- observer reproducibility study [J]. AJNR Am J Neuroradiol, 2011, 32: 2073-2079.
[18] Kim HR, Kim SH, Lee JI, et al. Outcome of radiosurgery for recurrent malignant gliomas: assessment of treatment response using relative cerebral blood volume [J]. J Neuro- oncol, 2015, 121: 311-318.
[19] Schmainda KM, Prah M, Connelly J, et al. Dynamic-suscep- tibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma [J]. Neuro Oncol, 2014, 16: 880-888.
[20] Deng ZX, Yan Y, Zhong D, et al. Quantitative analysis of glioma cell invasion by diffusion tensor imaging [J]. J Clin Neurosci, 2010, 17(12): 1530-1536.
[21] Castellano A, Bello L, Michelozzi C, et al. Role of diffusion tensor magnetic resonance tractography in predicting the extent of resection in glioma surgery [J]. Neuro Oncol, 2012, 14(2): 192-202.
[22] 白雪菲,牛广明,韩晓东,等. PWI和DWI技术在鉴别脑 胶质瘤复发与放射性脑损伤中的价值[J]. 磁共振成像, 2014,1:7-10.
[23] Cho JM, Kim EH, Kim J, et al. Clinical use of diffusion ten- sor image-merged functional neuronavigation for brain tumor surgeries: review of preoperative, intraoperative, and postoperative data for 123 cases [J]. Yonsei Med J, 2014, 55 (5): 1303-1309.
[24] 白雪东,孙夕林,王 丹,等. 动态对比增强MRI在鉴别 胶质瘤复发及放射性脑损伤中的应用[J]. 磁共振成像, 2014,5:1-6.

相似文献/References:

[1]付 锴 江普查 宫 睿 王 伟.表达VASH1基因的人脑胶质瘤U-87MG细胞对化疗药物敏感性的变化[J].中国临床神经外科杂志,2016,(01):34.[doi:10.13798/j.issn.1009-153X.2016.01.012]
 FU Kai,JIANG Pu-cha,GONG Rui,et al.Effect of lentiviral vector-mediated VASH1 gene on chemosensitivity of human glioma U-87MG cells[J].,2016,(04):34.[doi:10.13798/j.issn.1009-153X.2016.01.012]
[2]郎胜坤 许厚银 董月青 马铁柱 孙 艳 郝芊芊 王慧敏.磁共振灌注成像评估蛛网膜下腔出血后脑血管痉挛的价值[J].中国临床神经外科杂志,2016,(09):517.[doi:10.13798/j.issn.1009-153X.2016.09.002]
 LANG Sheng-kuan,XU Hou-yin,DONG Yue-qing,et al.Evaluation of cerebral vasospasm after aneurysmal subarachnoid hemorrhage by magnetic resonance perfusion weighted imaging[J].,2016,(04):517.[doi:10.13798/j.issn.1009-153X.2016.09.002]
[3]崔焕喜,柳 琛.多模态MRI、神经导航和超声在脑胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(11):721.[doi:10.13798/j.issn.1009-153X.2016.11.027]
[4]闫 珊 徐善才.多学科护理照顾模式对脑胶质瘤术后病人自我护理能力的影响[J].中国临床神经外科杂志,2017,(05):352.[doi:10.13798/j.issn.1009-153X.2017.05.026]
 YAN Shan,XU Shan-cai..Effects of multi-subjects nursing care model on self-care ability in patients with brain glioma after operation[J].,2017,(04):352.[doi:10.13798/j.issn.1009-153X.2017.05.026]
[5]罗似亮 夏之柏.脑胶质瘤病人脑脊液Midkine表达的临床意义[J].中国临床神经外科杂志,2017,(06):416.[doi:10.13798/j.issn.1009-153X.2017.06.017]
 LUO Si-liang,XIA Zhi-bo..Clinical meanings of midkine expression in cerebrospinal fluid of patients with gliomas[J].,2017,(04):416.[doi:10.13798/j.issn.1009-153X.2017.06.017]
[6]呼铁民 褚会松 田 甜 王昆鹏 杨国军 杨立军 王维兴.脑胶质瘤ADAM17与EGFR的表达及临床意义[J].中国临床神经外科杂志,2017,(08):557.[doi:10.13798/j.issn.1009-153X.2017.08.012]
 HU Tie-min,CHU Hui-song,TIAN Tian,et al.Expressions of ADAM17 and EGFR in gliomas tissues and their clinical meanings[J].,2017,(04):557.[doi:10.13798/j.issn.1009-153X.2017.08.012]
[7]汪超甲 综述 王 辉 审校.脑胶质瘤化疗现状及耐药机制的研究进展[J].中国临床神经外科杂志,2017,(11):791.[doi:10.13798/j.issn.1009-153X.2017.11.023]
[8]高剑峰 姚庆和 李晓辉 龙宇波 陈振波.脑胶质瘤miR-9、PPARγ表达水平及临床意义[J].中国临床神经外科杂志,2018,(01):17.[doi:10.13798/j.issn.1009-153X.2018.01.006]
 GAO Jian-feng,YAO Qing-he,LI Xiao-hui,et al.Expressions of miR-9 and PPARγ in human brain gliomas and their clinical meanings[J].,2018,(04):17.[doi:10.13798/j.issn.1009-153X.2018.01.006]
[9]刘 靖 吴立权 黄书岚.聚焦解决模式对脑胶质瘤术后病人自我管理效能感及生命意义的影响[J].中国临床神经外科杂志,2018,(03):208.[doi:10.13798/j.issn.1009-153X.2018.03.025]
 LIU Jing,WU Li-quan,HUANG Shu-lan..Effects of solution focused intervention on self-management efficacy and meanings of life in the patients with gliomas after surgery[J].,2018,(04):208.[doi:10.13798/j.issn.1009-153X.2018.03.025]
[10]刘 炎 杭春华.脑胶质瘤卒中误诊为脑动静脉畸形并出血1例[J].中国临床神经外科杂志,2018,(06):448.[doi:10.13798/j.issn.1009-153X.2018.06.025]

备注/Memo

备注/Memo:
通讯作者:陈谦学,E-mail:chenqx666@whu.edu.cn (2019-09-03收稿,2019-11-08修回)
更新日期/Last Update: 2020-04-10